National University Hospital, Singapore
Clinical trials sponsored by National University Hospital, Singapore, explained in plain language.
-
New dental sealer tested for better root canal healing
Disease control OngoingThis study compares two materials used to seal root canals after treatment. Researchers want to see if a newer bioceramic sealer (TotalFill) leads to better healing of the bone around the tooth root compared to a commonly used sealer (AH Plus). They will also track patients' pain…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug duo aims to shrink breast tumors before surgery
Disease control OngoingThis study is testing whether adding a drug called lenvatinib to standard hormone therapy (letrozole) can better shrink breast tumors before surgery. It involves post-menopausal women with newly diagnosed, hormone receptor-positive breast cancer. The research first aims to find a…
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain scans could predict stroke recovery, guide better therapy
Disease control OngoingThis study aims to understand how the brain changes after a stroke to predict how well a person's arm will recover. Researchers will use brain scans and tests to track recovery over a year. For some participants, they will also test if a mild, non-invasive brain stimulation treat…
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First-in-Human cancer antibody trial begins
Disease control OngoingThis is the first study to test a new antibody drug called PRL3-ZUMAB in people. The goal is to find a safe dose for patients with advanced solid tumors or blood cancers that have stopped responding to standard treatments. Researchers will give increasing doses to small groups of…
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Singapore hospital tests novel RNA therapy in fight against advanced liver cancer
Disease control OngoingThis early-stage study is testing the safety and best dose of a new three-drug combination for people with advanced liver cancer (hepatocellular carcinoma) who haven't had other drug treatments. The combination adds a new experimental RNA drug (MTL-CEBPA) to two existing cancer d…
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Antibiotic joins fight against tough pancreatic cancer
Disease control OngoingThis small, early-stage study is testing whether adding a common antibiotic called ciprofloxacin to standard chemotherapy can help control advanced pancreatic cancer that has spread. It will involve 10 patients who are about to start their first chemotherapy treatment. The goal i…
Phase: PHASE1 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New pill trial aims to halt spread of Tough-to-Treat breast cancer
Disease control OngoingThis study is testing an oral drug called Lonsurf in people whose breast cancer has spread and worsened despite other treatments. It aims to see if the drug can slow or stop the cancer's growth for a meaningful period. The trial will enroll 86 participants, including those who ha…
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Targeted drug trial seeks to control Tough-to-Treat cancers
Disease control OngoingThis study is testing if the drug pacritinib can help control the growth of advanced solid tumors that have a specific genetic feature called 1q21.3 amplification. It is enrolling up to 74 adults with cancers, mostly breast cancer, that have stopped responding to standard treatme…
Phase: PHASE1, PHASE2 • Sponsor: National University Hospital, Singapore • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC
-
Your face could warn doctors of anesthesia danger
Diagnosis OngoingThis study is testing a new AI tool that scans a patient's face to predict if placing a breathing tube will be difficult before surgery. It aims to help anesthesiologists identify high-risk patients in advance to improve safety. The system analyzes facial structure using a 3D sca…
Sponsor: National University Hospital, Singapore • Aim: Diagnosis
Last updated Mar 19, 2026 14:56 UTC
-
Singapore trial aims to boost low breast cancer screening rates with simple reminders
Prevention ENROLLING_BY_INVITATIONThis study is testing different outreach methods, like mailers and app notifications, to see which ones best encourage women in Singapore to schedule and attend their mammogram appointments. It focuses on two groups: women who have never had a mammogram and women who are overdue …
Phase: NA • Sponsor: National University Hospital, Singapore • Aim: Prevention
Last updated Mar 25, 2026 14:08 UTC
-
Knee surgery breakthrough? new numbing drug promises quicker recovery
Symptom relief OngoingThis study compares two numbing medicines (bupivacaine and prilocaine) given via spinal injection for knee replacement surgery. It aims to see if prilocaine allows patients to regain leg movement faster after surgery, which could help them start rehabilitation sooner and potentia…
Phase: PHASE4 • Sponsor: National University Hospital, Singapore • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Singapore launches 20-Year quest to unlock secrets of health from womb to adulthood
Knowledge-focused OngoingThis long-term study aims to understand how a mother's health, lifestyle, and environment during pregnancy, combined with a child's early life, influence the risk of developing future health problems like diabetes, obesity, and mental health conditions. Researchers are following …
Sponsor: National University Hospital, Singapore • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:35 UTC